(Q36327355)

13 August 2017

1 reference

title

Immunotherapy for the prevention and treatment of type 1 diabetes (English)

1 reference

13 August 2017

0 references

1 reference

Kevin S Goudy

1

1 reference

13 August 2017

Roland Tisch

series ordinal

2

1 reference

13 August 2017

language of work or name

1 reference

1 September 2005

1 reference

International Reviews of Immunology

13 August 2017

published in

1 reference

13 August 2017

volume

24

1 reference

13 August 2017

issue

5-6

1 reference

13 August 2017

page(s)

307-326

1 reference

Genetic epidemiology of diabetes

13 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

A single course of anti-CD3 monoclonal antibody hOKT3gamma1(Ala-Ala) results in improvement in C-peptide responses and clinical parameters for at least 2 years after onset of type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Anti-CD3 monoclonal antibody in new-onset type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Effects of insulin in relatives of patients with type 1 diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

The NOD mouse: a model of immune dysregulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

The stages of type 1A diabetes: 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Checkpoints in the progression of autoimmune disease: lessons from diabetes models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

The nonobese diabetic mouse as a model of autoimmune diabetes: immune dysregulation gets the NOD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Genetic protection from the inflammatory disease type 1 diabetes in humans and animal models

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Spontaneous loss of T-cell tolerance to glutamic acid decarboxylase in murine insulin-dependent diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Immune response to glutamic acid decarboxylase correlates with insulitis in non-obese diabetic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Insulin-specific T cells are a predominant component of islet infiltrates in pre-diabetic NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Identification of an MHC class I-restricted autoantigen in type 1 diabetes by screening an organ-specific cDNA library.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Spontaneous peripheral T-cell responses to the IA-2beta (phogrin) autoantigen in young nonobese diabetic mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

A role of Hsp60 in autoimmune diabetes: analysis in a transgenic model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Immunoregulatory and cytokine imbalances in the pathogenesis of IDDM. Therapeutic intervention by immunostimulation?

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Autoreactive T cell responses show proinflammatory polarization in diabetes but a regulatory phenotype in health

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

CD4+CD25+ T regulatory cells dependent on ICOS promote regulation of effector cells in the prediabetic lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Single cell analysis shows decreasing FoxP3 and TGFbeta1 coexpressing CD4+CD25+ regulatory T cells during autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Autoimmune diabetes onset results from qualitative rather than quantitative age-dependent changes in pathogenic T-cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Development and function of CD25+CD4+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Regulation of immunity by self-reactive T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Foxp3 programs the development and function of CD4+CD25+ regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Control of regulatory T cell development by the transcription factor Foxp3

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

TGF-beta-dependent mechanisms mediate restoration of self-tolerance induced by antibodies to CD3 in overt autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Conversion of CD4+ CD25- cells into CD4+ CD25+ regulatory T cells in vivo requires B7 costimulation, but not the thymus

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Multiple immuno-regulatory defects in type-1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Toward an understanding of NKT cell biology: progress and paradoxes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Developmental control of CD8 T cell-avidity maturation in autoimmune diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

A comprehensive review of interventions in the NOD mouse and implications for translation

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Beta-cell function in new-onset type 1 diabetes and immunomodulation with a heat-shock protein peptide (DiaPep277): a randomised, double-blind, phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Use of inhaled insulin in a basal/bolus insulin regimen in type 1 diabetic subjects: a 6-month, randomized, comparative trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Antigen-based therapies using ignored determinants of beta cell antigens can more effectively inhibit late-stage autoimmune disease in diabetes-prone mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Understanding crypticity is the key to revealing the pathogenesis of autoimmunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Suppression of diabetes in nonobese diabetic mice by oral administration of porcine insulin

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Pancreatic beta-cell function and immune responses to insulin after administration of intranasal insulin to humans at risk for type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

A T cell receptor antagonist peptide induces T cells that mediate bystander suppression and prevent autoimmune encephalomyelitis induced with multiple myelin antigens

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Altered peptide ligand-induced partial T cell activation: molecular mechanisms and role in T cell biology

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Immunological characterization and therapeutic activity of an altered-peptide ligand, NBI-6024, based on the immunodominant type 1 diabetes autoantigen insulin B-chain (9-23) peptide

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Transient blockade of CD40 ligand dissociates pathogenic from protective mucosal immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Tolerogenic dendritic cells induced by vitamin D receptor ligands enhance regulatory T cells inhibiting allograft rejection and autoimmune diseases.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Induction of regulatory dendritic cells by dexamethasone and 1alpha,25-Dihydroxyvitamin D(3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Modulation of CD1d-restricted NKT cell responses by using N-acyl variants of alpha-galactosylceramides

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Activation of CD1d-restricted T cells protects NOD mice from developing diabetes by regulating dendritic cell subsets

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Natural killer T cells contribute to airway eosinophilic inflammation induced by ragweed through enhanced IL-4 and eotaxin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

CD1d-dependent activation of NKT cells aggravates atherosclerosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

CD3-specific antibody-induced active tolerance: from bench to bedside

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Interleukin-10 suppression of myeloid cell activation--a continuing puzzle

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Antigen-specific inhibition of effector T cell function in humans after injection of immature dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

IL-10 is a key cytokine in psoriasis. Proof of principle by IL-10 therapy: a new therapeutic approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Adeno-associated virus vector-mediated IL-10 gene delivery prevents type 1 diabetes in NOD mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Adeno-associated virus-mediated IL-10 gene therapy inhibits diabetes recurrence in syngeneic islet cell transplantation of NOD mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Inducible long-term gene expression in brain with adeno-associated virus gene transfer

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Favorably tipping the balance between cytopathic and regulatory T cells to create transplantation tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Induction of Autoimmune Diabetes by Oral Administration of Autoantigen

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

Induction of a non-encephalitogenic type 2 T helper-cell autoimmune responsein multiple sclerosis after administration of an altered peptide ligand ina placebo-controlled, randomized phase II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1080%2F08830180500379721

10.1080/08830180500379721

21 January 2018

Identifiers

DOI

1 reference

13 August 2017

1 reference